Table of Contents Table of Contents
Previous Page  1614-1615 / 1674 Next Page
Information
Show Menu
Previous Page 1614-1615 / 1674 Next Page
Page Background

University Hospital Erlangen

In-Breast Recurrence

Institute

FUP

years

No. of pts.

BCS

vs

.

MRM

Crude 2

nd.

LR%

BCS

vs

.

MRM

5-y 2

nd.

LR%

BCS

vs.

MRM

5-y OS%

BCS

vs.

MRM

EIO, Milan

3.7

161 vs. 0

21 vs. -

31 vs. -

82 vs. -

EIO, Milan

6.1

57 vs. 133

14 vs. 3

19 vs. 4

85 vs. 70

NIO, Budapest

14

32 vs. 32

28 vs. 16

NR

77 vs. 55

Karolinska Hosp.

6

14 vs. 65

50 vs. 18

33 vs. 12

NR

Dutch Study Group

4.3

20 vs. 229

40 vs. 22

NR

NR

Yale-New Haven Hosp

14

30 vs. 116

7 vs. 7

NR

66 vs. 58

Osaka Med. Center

3.6

30 vs. 11

30 vs. 0

37 vs. 0

90 vs. 91

JCRT, Boston

3.3

16 vs. 123

31 vs. 6

NR

NR vs. 79

Marseille Cancer Inst.

3

34 vs. 36

9 vs. 3

22 vs. 4

NR

Marseille Cancer Inst.

6

52 vs. 0

23 vs. -

21 vs. -

79 vs. -

Marseille Cancer Inst.

4.3

50 vs. 0

32 vs. -

38 vs. -

67 vs. -

Univ. Pennsylvania

3.7

0 vs. 112

- vs. 3

NR

- vs. 86

All patients

3-14

496

vs.

857

23%

vs.

11%

19-38%

vs.

0-12%

66-90%

vs.

55-91%

Results of

2

nd.

Breast conserving surgery (BCS) without RT

versus

modified radical mastectomy (MRM)